Literature DB >> 30525111

Epigenetic inhibitors for the precision treatment of ARID1A-mutant ovarian cancers: what are the next steps?

Takeshi Fukumoto1, Rugang Zhang1, Benjamin G Bitler2.   

Abstract

Entities:  

Keywords:  ARID1A; EZH2; Epigenetics; HDAC; SWI/SNF; ovarian cancer

Year:  2018        PMID： 30525111      PMCID： PMC6277026          DOI： 10.1080/23808993.2018.1503050

Source DB:  PubMed          Journal:  Expert Rev Precis Med Drug Dev        ISSN： 2380-8993


× No keyword cloud information.
  29 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  A new world of Polycombs: unexpected partnerships and emerging functions.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2013-11-12       Impact factor: 53.242

3.  5-Azacytidine, a new, highly effective cancerostatic.

Authors:  F Sorm; A Pískala; A Cihák; J Veselý
Journal:  Experientia       Date:  1964-04-15

4.  Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.

Authors:  Junzo Hamanishi; Masaki Mandai; Takafumi Ikeda; Manabu Minami; Atsushi Kawaguchi; Toshinori Murayama; Masashi Kanai; Yukiko Mori; Shigemi Matsumoto; Shunsuke Chikuma; Noriomi Matsumura; Kaoru Abiko; Tsukasa Baba; Ken Yamaguchi; Akihiko Ueda; Yuko Hosoe; Satoshi Morita; Masayuki Yokode; Akira Shimizu; Tasuku Honjo; Ikuo Konishi
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

5.  ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.

Authors:  Jianfeng Shen; Zhenlin Ju; Wei Zhao; Lulu Wang; Yang Peng; Zhongqi Ge; Zachary D Nagel; Jun Zou; Chen Wang; Prabodh Kapoor; Xiangyi Ma; Ding Ma; Jiyong Liang; Shumei Song; Jinsong Liu; Leona D Samson; Jaffer A Ajani; Guo-Min Li; Han Liang; Xuetong Shen; Gordon B Mills; Guang Peng
Journal:  Nat Med       Date:  2018-05-07       Impact factor: 53.440

6.  Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.

Authors:  Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard Roden; Ruth Glas; Dennis Slamon; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Science       Date:  2010-09-08       Impact factor: 47.728

7.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors:  Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal:  Nat Genet       Date:  2013-05-05       Impact factor: 38.330

Review 8.  Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription.

Authors:  Liling Tang; Eva Nogales; Claudio Ciferri
Journal:  Prog Biophys Mol Biol       Date:  2010-05-20       Impact factor: 3.667

9.  Discovery and saturation analysis of cancer genes across 21 tumour types.

Authors:  Michael S Lawrence; Petar Stojanov; Craig H Mermel; James T Robinson; Levi A Garraway; Todd R Golub; Matthew Meyerson; Stacey B Gabriel; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2014-01-05       Impact factor: 49.962

Review 10.  ARID1A gene mutation in ovarian and endometrial cancers (Review).

Authors:  Takashi Takeda; Kouji Banno; Ryuichiro Okawa; Megumi Yanokura; Moito Iijima; Haruko Irie-Kunitomi; Kanako Nakamura; Miho Iida; Masataka Adachi; Kiyoko Umene; Yuya Nogami; Kenta Masuda; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Oncol Rep       Date:  2015-11-16       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.